Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5
Summary
Emyria Limited has entered into a binding Term Sheet (Agreement) with Aspen Pharmacare Australia (Aspen Australia) for the licensing and commercialisation of EMD-RX5.
Your question will be sent privately to Emyria. The company may choose to make this question public.
